ENDO ONE launches diode endolaser platform for aesthetic clinics

ENDO ONE SRL is pitching a new diode endolaser platform for aesthetic practices that want skin tightening, tissue retraction and collagen stimulation without incisional surgery. The company says the system is designed to fit clinic workflows, expand treatment options and meet international quality standards.

Why it matters: - Aesthetic clinics are looking for treatments that deliver visible lifting and tightening without the downtime, scarring or surgical risk of incisional procedures. - ENDO ONE is positioning its platform as a middle ground between superficial skin-tightening devices and invasive plastic surgery. - The system is designed for practices that want to broaden facial and body treatment offerings while keeping workflow efficient.

What happened: - ENDO ONE SRL introduced ENDO ONE, an advanced diode endolaser platform for aesthetic medicine. - The platform was developed through a transatlantic collaboration between frontline clinical practitioners and ENDO ONE SRL in Italy. - ENDO ONE says the device targets the reticular dermis and subdermal tissue planes for subcutaneous rejuvenation. - The company says the platform is intended for use in aesthetic clinics, outpatient surgical facilities and other professional medical settings. - Interested practices can review specifications and submit inquiries through the official website.

The details: - The device uses a GaAlAs semiconductor diode delivery system. - The chassis measures 39 cm by 32 cm by 23 cm. - The system weighs 8.5 kg. - A high-resolution touchscreen is built in for parameter selection. - The platform includes an adjustable 650 nm red aiming beam. - The aiming beam helps confirm fiber-tip position and subcutaneous depth during treatment. - Precision optical fibers deliver energy through minimal puncture sites created with a fine-gauge needle. - ENDO ONE says the treatment avoids surgical incisions, sutures and visible scars. - Clinicians can set patient-specific protocols, pulse durations and energy levels from the interface. - The company says clinicians perform retrograde passes at roughly 1 cm per second. - Continuous non-contact thermal monitoring keeps epidermal temperatures below 40 to 42 degrees Celsius. - The platform is intended to support tissue tightening, collagen stimulation and immediate tissue retraction. - The device is designed to remain stable during extended operational cycles with minimal thermal drift. - The handpiece and fiber-coupling system are balanced to provide tactile feedback during subcutaneous navigation.

Between the lines: - ENDO ONE is marketing the product around workflow and precision as much as clinical outcome. - The emphasis on ergonomic design, compact size and touch-screen controls suggests the company is targeting busy practices that want faster setup and more predictable procedures. - The collaboration with Italian engineering is meant to reinforce credibility in a crowded energy-device market. - The broader message is that device design, not just energy output, may be a key differentiator for aesthetic clinics.

What's next: - ENDO ONE says it will continue expanding clinical presence in international markets. - The company is working with aesthetic physicians to document outcomes and refine procedural protocols. - Practitioner training and technical documentation are part of the rollout. - Clinics can use the company’s digital consultation portal to request platform overviews, consumable details and commercial integration guidance.

The bottom line: - ENDO ONE is trying to win aesthetic clinics with a compact, clinic-friendly endolaser platform that combines subcutaneous precision, safety controls and multi-application use.